CASI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
CASI Pharmaceuticals Inc is not a strong buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock lacks significant positive catalysts, has weak financial performance, and shows no clear technical or options-based trading signals. It is better to hold off on investing in this stock at the moment.
The technical indicators suggest a bearish trend. The MACD is below 0 and negatively contracting, RSI is neutral at 38.907, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with support at 0.758 and resistance at 0.979.
No significant positive catalysts identified. The stock has no recent news, and there are no strong trading trends from hedge funds or insiders.
Gross margin also declined sharply by -55.77% YoY. Technical indicators point to a bearish trend, and there are no recent signals from Intellectia Proprietary Trading Signals.
In Q3 2025, revenue dropped significantly by -60.54% YoY to $3,075,000. Net income improved slightly but remains negative at -$10,883,000, up 29.64% YoY. EPS improved to -0.68, up 23.64% YoY, but gross margin fell sharply to 22.96%, down -55.77% YoY.
No recent analyst rating or price target changes available for CASI Pharmaceuticals Inc.
